Table 1 Clinical characteristics and cohort distribution of the study population
Obesity status | Glycemic status | Population | N | Sex ratio (men:women) | Age at examination (years) | BMI (kg/m2) |
|---|---|---|---|---|---|---|
Non-obese | NG | French case-control group | 1,067 | 477:590 | 46 ± 15 | 24.3 ± 3.0 |
French D.E.S.I.R. cohort | 2,122 | 880:1,242 | 47 ± 10 | 22.7 ± 2.3 | ||
Swiss group | na | na | na | na | ||
Overall | 3,189 | 1357:1832 | 47 ± 12 | 23.3 ± 2.6 | ||
T2D | French case-control group | 1,244 | 805:439 | 60 ± 11 | 26.2 ± 2.6 | |
French D.E.S.I.R. cohort | na | na | na | na | ||
Swiss group | na | na | na | na | ||
Overall | 1,244 | 805:439 | 60 ± 11 | 26.2 ± 2.6 | ||
Obese | NG | French case-control group | 678 | 181:497 | 41 ± 11 | 41.0 ± 8.2 |
French D.E.S.I.R. cohort | na | na | na | na | ||
Swiss group | 605 | 128:477 | 42 ± 10 | 43.7 ± 7.0 | ||
Overall | 1,283 | 309:974 | 42 ± 11 | 42.2 ± 7.8 | ||
T2D | French case-control group | 1,347 | 645:702 | 56 ± 11 | 36.8 ± 7.1 | |
French D.E.S.I.R. cohort | na | na | na | na | ||
Swiss group | 234 | 66:168 | 46 ± 11 | 42.7 ± 7.2 | ||
Overall | 1,581 | 711:870 | 54 ± 12 | 37.1 ± 7.4 |